Koyfin Home > Directory > Health Care > Abbott Laboratories > Repurchase of Common Stock

Abbott Laboratories Repurchase of Common Stock Chart (ABT)

Abbott Laboratories annual/quarterly Repurchase of Common Stock from 2010 to 2020.
  • Abbott Laboratories Repurchase of Common Stock for the quarter ending September 09, 2020 was $-2m a -24,700.00% increase of 494m year over year
  • Abbott Laboratories Repurchase of Common Stock for the last 12 months ending September 09, 2020 was $-738m a 2.71% decrease of -20m year over year
  • Abbott Laboratories Annual Repurchase of Common Stock for 2019 was $-718m a 66.85% decrease of -480m from 2018
  • Abbott Laboratories Annual Repurchase of Common Stock for 2018 was $-238m a 50.84% decrease of -121m from 2017
  • Abbott Laboratories Annual Repurchase of Common Stock for 2017 was $-117m a -346.15% increase of 405m from 2016
Other Cash Flow Metrics:
  • Abbott Laboratories Cash Flow from Operations for the quarter ending September 09, 2018 was $2,183m a 8.15% increase of 178m year over year
  • Abbott Laboratories Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $1,647m a 6.17% increase of 102m year over year
  • Abbott Laboratories Total Revenue for the quarter ending December 12, 2018 was $7,765m a 4.83% increase of 375m year over year
View Chart On Koyfin

Quarterly ABT Repurchase of Common Stock Data

09/2020$-2m
06/2020$-4m
03/2020$-236m
12/2019$-496m
09/2019$-1m
06/2019$-4m
03/2019$-217m
12/2018$-104m
09/2018$-3m
06/2018$-3m

Annual ABT Repurchase of Common Stock Data

2019$-718m
2018$-238m
2017$-117m
2016$-522m
2015$-2,237m
2014$-2,195m
2013$-1,605m
2012$-2,364m
2011$-77m
2010$-867m